Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding
- PMID: 21321285
- PMCID: PMC3142477
- DOI: 10.1001/archinternmed.2011.14
Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding
Abstract
Background: Acid-suppressive medications are increasingly prescribed for noncritically ill hospitalized patients, although the incidence of nosocomial gastrointestinal (GI) tract bleeding (GI bleeding) and magnitude of potential benefit from this practice are unknown. We aimed to define the incidence of nosocomial GI bleeding outside of the intensive care unit and examine the association between acid-suppressive medication use and this complication.
Methods: We conducted a pharmacoepidemiologic cohort study of patients admitted to an academic medical center from 2004 through 2007, at least 18 years of age, and hospitalized for 3 or more days. Admissions with a primary diagnosis of GI bleeding were excluded. Acid-suppressive medication use was defined as any order for a proton pump inhibitor or histamine-2-receptor antagonist. The main outcome measure was nosocomial GI bleeding. A propensity matched generalized estimating equation was used to control for confounders.
Results: The final cohort included 78,394 admissions (median age, 56 years; 41% men). Acid-suppressive medication was ordered in 59% of admissions, and nosocomial GI bleeding occurred in 224 admissions (0.29%). After matching on the propensity score, the adjusted odds ratio for nosocomial GI bleeding in the group exposed to acid-suppressive medication relative to the unexposed group was 0.63 (95% confidence interval, 0.42-0.93). The number needed to treat to prevent 1 episode of nosocomial GI bleeding was 770.
Conclusions: Nosocomial GI bleeding outside of the intensive care unit was rare. Despite a protective effect of acid-suppressive medication, the number needed to treat to prevent 1 case of nosocomial GI bleeding was relatively high, supporting the recommendation against routine use of prophylactic acid-suppressive medication in noncritically ill hospitalized patients.
Conflict of interest statement
None of the authors have any financial conflicts of interest or disclosures to report.
Figures
Comment in
-
Acid suppressive therapy in noncritically ill patients.Arch Intern Med. 2011 Nov 14;171(20):1861; author reply 1861-2. doi: 10.1001/archinternmed.2011.513. Arch Intern Med. 2011. PMID: 22083578 No abstract available.
Similar articles
-
Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients.J Gen Intern Med. 2013 May;28(5):683-90. doi: 10.1007/s11606-012-2296-x. Epub 2013 Jan 5. J Gen Intern Med. 2013. PMID: 23292499 Free PMC article.
-
Acid-suppressive medication use and the risk for hospital-acquired pneumonia.JAMA. 2009 May 27;301(20):2120-8. doi: 10.1001/jama.2009.722. JAMA. 2009. PMID: 19470989
-
Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.Ann Neurol. 2014 Nov;76(5):712-8. doi: 10.1002/ana.24262. Epub 2014 Sep 17. Ann Neurol. 2014. PMID: 25164323 Free PMC article.
-
Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.Crit Care Med. 2013 Mar;41(3):693-705. doi: 10.1097/CCM.0b013e3182758734. Crit Care Med. 2013. PMID: 23318494 Review.
-
Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.BMC Gastroenterol. 2019 Nov 21;19(1):193. doi: 10.1186/s12876-019-1105-y. BMC Gastroenterol. 2019. PMID: 31752703 Free PMC article. Review.
Cited by
-
An Updated Review and a Case Report: Stress Ulcer Prophylaxis.Cureus. 2024 May 21;16(5):e60811. doi: 10.7759/cureus.60811. eCollection 2024 May. Cureus. 2024. PMID: 38910681 Free PMC article.
-
Associations between COVID-19 therapies and inpatient gastrointestinal bleeding: A multisite retrospective study.J Med Virol. 2023 Oct;95(10):e29100. doi: 10.1002/jmv.29100. J Med Virol. 2023. PMID: 37786247 Free PMC article.
-
Association between hospital-acquired pneumonia and proton pump inhibitor prophylaxis in patients treated with glucocorticoids: a retrospective cohort study based on 307,622 admissions in China.J Thorac Dis. 2022 Jun;14(6):2022-2033. doi: 10.21037/jtd-21-1886. J Thorac Dis. 2022. PMID: 35813745 Free PMC article.
-
Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study.Front Pharmacol. 2022 Jun 2;13:881063. doi: 10.3389/fphar.2022.881063. eCollection 2022. Front Pharmacol. 2022. PMID: 35721126 Free PMC article.
-
Review of Proton Pump Inhibitor Overuse in the US Veteran Population.J Pharm Technol. 2015 Aug;31(4):167-176. doi: 10.1177/8755122515575177. Epub 2015 Mar 9. J Pharm Technol. 2015. PMID: 34860933 Free PMC article.
References
-
- Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. Jama. 2009;301:2120–8. - PubMed
-
- Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95:3118–22. - PubMed
-
- Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006;40:1261–6. - PubMed
-
- Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007;64:1396–400. - PubMed
-
- Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006;101:2200–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
